Clinical trials look at new ways to prevent, detect or treat gastrointestinal diseases or conditions, while also providing valuable information about health and disease progress. Colonoscopy is the most important step in the prevention of colon cancer. Colonoscopy is the only colon cancer screening method that allows your gastroenterologist to visualize the entire colon and remove most polyps at the same time.

The most important step prior to your colonoscopy is cleaning out your colon. This will allow your physician to discover and remove polyps. Learn more about a new trial on colonoscopy prep.

Contact Research

Difficulty Swallowing EoE

Eosinophilic esophagitis (EoE) is a chronic disease of the esophagus. If you have EoE, white blood cells called eosinophils build up in your esophagus. EOE symptoms can cause damage and inflammation, causing pain, and may lead to difficulty swallowing, food getting stuck in your throat, or dysphagia.

If you have difficulty swallowing or symptoms of EOE, you should have symptoms reviewed by a gastroenterologist.

You may be eligible for a clinical research study if you have a confirmed diagnosis of eosinophilic esophagitis (EoE), eosinophilic gastritis, or eosinophilic duodenitis (EG/EoD).

Contact Research

ClinicalTrials.gov Study Details

Eosinophilic Esophagitis
Clinical Research Protocol AK002-014 A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AK002 in Adult and Adolescent Patients with Active Eosinophilic Esophagitis

Gastroparesis is a condition that affects the normal spontaneous movement of the muscles (motility) in your stomach causing food to stay in your stomach for longer than it should.  Gastroparesis can cause a feeling of fullness, nausea and vomiting.

Encore Borland Groover Research is actively recruiting patient volunteer for a Gastroparesis study in Jacksonville.

ClinicalTrials.gov Study Details
Symptomatic Diabetic or Idiopathic Gastroparesis
Protocol Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of NG101 Administered Orally to Patients with Gastroparesis Protocol Number: NG101-201
Contact Research

Eosinophilic Gastroenteritis/Duodenitis

---

Eosinophilic Gastroenteritis/Duodenitis is a rare disease in which a type of white blood cell, the eosinophil, causes injury and inflammation to the stomach and the small intestine. Eosinophilic gastroenteritis may affect both adults and children. The cause is unknown.

Symptoms:

• Vomiting, nausea, diarrhea
• Difficulty feeding and/or gaining weight
• Poor growth and weight loss
• Abdominal pain
• Bloody diarrhea
• Malnutrition
• Fatigue

Current Clinical Trials

---

ClinicalTrials.gov Study Details
Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis) (ENIGMA 2)
Clinical Research Protocol AK002-016 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AK002 in Patients with Moderately to Severely Active Eosinophilic Gastritis and/or Eosinophilic Duodenitis (formerly referred to as Eosinophilic Gastroenteritis) Who Have an Inadequate Response with, Lost Response to, or Were Intolerant to Standard Therapies

Clinical Research Protocol AK002-019 A Prospective Study to Identify the Prevalence of Eosinophilic Gastrointestinal Diseases and Elevated Tissue Mast Cells among Patients with Chronic Gastrointestinal Symptoms

Dr. Lankarani reviews the link between Eosinophilic Gastroenteritis and IBS.

https://vimeo.com/391591255 Contact Research